title: MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate.
abstract: Primary basal cell carcinoma of the prostate is a very rare neoplasm with a good prognosis. A 55-year-old man presented with urinary frequency for 2 months. Serum prostate-specific antigen level was normal. T2-weighted MR images showed an inhomogeneously hyperintense tumor in the prostate. Enhanced CT showed heterogeneous enhancement of the tumor. FDG PET/CT showed strong FDG uptake of the tumor with SUVmax of 14.1. Prostate biopsy findings revealed basal cell carcinoma with high proliferation index.
authors.affiliation: From the Departments of *Nuclear Medicine; †Radiology; and ‡Pathology, Changhai Hospital, Second Military Medical University, Shanghai, China.
authors.forename: Aisheng
authors.initials: A
authors.lastname: Dong
authors.forename: Changjing
authors.initials: C
authors.lastname: Zuo
authors.forename: Jianping
authors.initials: J
authors.lastname: Lu
authors.forename: Yang
authors.initials: Y
authors.lastname: Wang
mesh_terms: D002280:Basal Cell Carcinoma / Q000175:diagnosis / Q000000981:diagnostic imaging*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18